U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07097103) titled 'Parkinson's Research In Metagenomic Early Stage Biomarkers' on June 30.
Brief Summary: This 2x2 factorial, randomized, controlled pilot study aims to identify a specific microbiota pattern, which could constitute a biomarker of Parkinson's disease, and to evaluate whether specific pathotypes can be associated with different stages of the disease; furthermore, the investigators are committed to evaluating how and to what extent the changes induced by a personalized nutritional intervention combined with physical exercise affect the symptoms and quality of life of patients.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condi...